drugset / Trial / NCT04146805
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase 1a, Double Blind, Placebo-Controlled, Single-Center, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Volunteers
Timeline
- Start
- 2020-01-10
- Primary completion
- 2020-12-03
- Completion
- 2021-04-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cudetaxestat | Small molecule | — | Oral |